Nanox signs 2 U.S. distribution deals for Nanox.ARC
Relevant. Nanox.ARC is an FDA-cleared multisource digital tomosynthesis system intended to expand 3D imaging access across healthcare and public sector settings.

Nano-X Imaging has signed 2 U.S. distribution agreements to expand deployment of its Nanox.ARC multisource digital tomosynthesis system. The agreements involve Howard Technology Solutions and Radiology Oncology Systems.
The Howard agreement calls for 300 systems to be marketed and deployed across the U.S. over 3 years. Nanox said 60 systems are planned for the first year.
Howard Technology Solutions will introduce the system to healthcare facilities and public sector customers through its national network. The company is a division of Howard Industries and provides technology procurement, deployment, and support services.
The second agreement names Radiology Oncology Systems as a U.S. distribution partner. The company will support commercial rollout of the system across hospitals and clinics, with a focus on oncology-adjacent care environments.
Nanox described the system as an FDA-cleared, multisource digital tomosynthesis platform. The company said it is designed to make 3D imaging available in more clinical settings at lower cost and reduced radiation dose compared with traditional CT.
In its fourth-quarter 2025 business update, Nanox said it had distribution agreements for approximately 360 Nanox.ARC systems in the U.S. over the next 2 to 3 years. The company said timing depends on regulatory, operational, and market factors.
About the author
RadiologySignal.com writersEditorial Team
Radiology Signal Staff covers developments across medical imaging, radiology AI, imaging informatics, clinical research, and radiology business. The team monitors primary sources, peer-reviewed studies, company announcements, society updates, and healthcare industry news to deliver concise reporting for imaging professionals.
More from this section

QT Imaging prices $10M public offering
QT Imaging Holdings priced a $10M underwritten public offering of common stock and pre-funded warrants. The breast imaging technology company plans to use proceeds for working capital and general corporate purposes.

EDAP, Telix explore PSMA PET and HIFU collaboration
EDAP TMS and Telix Pharmaceuticals signed a letter of intent to explore clinical research combining Focal One Robotic HIFU with Telix PSMA PET imaging agents in prostate cancer care.

UnitedHealthcare cites radiology costs in Maryland premium request
UnitedHealthcare is seeking an average 7.9% mid-year premium increase for some Maryland small-group plans. The insurer cited rising outpatient costs, including radiology, lab pathology, infusion, and radiation therapy.